A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss and Fat Loss

Description

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (Wegovy®). This study will be done in 3 parts, Part A, Part B, and Part C where different study drugs will be tested. Part A of the study is focused on healthy participants. Part B and C of the study is focused on participants with obesity. The aim of Part A of the study is to see how safe and tolerable the study drug is in healthy participants. The aim of Part B and Part C of the study is to see how safe and effective the study drug is when combined with Wegovy. Parts A, B, and C of the study are looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

Conditions

Obesity

Study Overview

Study Details

Study overview

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (Wegovy®). This study will be done in 3 parts, Part A, Part B, and Part C where different study drugs will be tested. Part A of the study is focused on healthy participants. Part B and C of the study is focused on participants with obesity. The aim of Part A of the study is to see how safe and tolerable the study drug is in healthy participants. The aim of Part B and Part C of the study is to see how safe and effective the study drug is when combined with Wegovy. Parts A, B, and C of the study are looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

A Randomized, Double-Blind Study of The Efficacy and Safety of Trevogrumab, With or Without Garetosmab, in Addition to Semaglutide in Patients With Obesity

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss and Fat Loss

Condition
Obesity
Intervention / Treatment

-

Contacts and Locations

Anniston

Pinnacle Research Group, Anniston, Alabama, United States, 36207

Cullman

Cullman Clinical Trials, Cullman, Alabama, United States, 35055

Phoenix

Foothills Research Center Cct Research, Phoenix, Arizona, United States, 85044

Anaheim

Anaheim Clinical Trials, Anaheim, California, United States, 92801

Chula Vista

ProSciento, Chula Vista, California, United States, 91911

Huntington Park

Valiance Clinical Research- Huntington Park, Huntington Park, California, United States, 91356

La Mesa

Velocity, San Diego, La Mesa, California, United States, 91941

Sacramento

Northern California Research, Sacramento, California, United States, 95821

San Diego

Acclaim Clinical Research, San Diego, California, United States, 92120

Tarzana

Metabolic Institute of America, Tarzana, California, United States, 91356

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 80 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Regeneron Pharmaceuticals,

    Clinical Trial Management, STUDY_DIRECTOR, Regeneron Pharmaceuticals

    Study Record Dates

    2026-11-20